Mr. Stephen Ito

Mr. Stephen Ito serves as a MMESO DHA Clinical Analyst, providing critical clinical and operational expertise to support defense health procurement decisions. In this role, he evaluates clinical requirements, validates technical specifications, and ensures that acquisition strategies align with military medical standards and operational needs. His work bridges clinical practice and contracting processes, enabling the Department of Defense to procure high-integrity surgical supplies and medical devices that meet rigorous battlefield and clinical care benchmarks. He is deeply involved in the early stages of acquisition planning, contributing technical input that shapes statement of work development, evaluation criteria, and vendor qualification standards. While no contractor relationships are currently documented in the system, Mr. Ito’s role typically involves collaboration with manufacturers and distributors of surgical appliances and medical supplies, engaging with vendors who demonstrate compliance with FDA regulations, ISO standards, and military-specific performance requirements. He works closely with contracting officers to ensure technical evaluations reflect real-world clinical utility, safety, and interoperability with existing military medical systems. Mr. Ito’s procurement portfolio reflects a strong preference for open competition, with 100% of acquisitions classified as “No Set-Aside.” This indicates a focus on technical merit, regulatory compliance, and performance outcomes over socioeconomic classifications, though he remains supportive of small business participation when vendors meet stringent clinical and quality benchmarks. His primary procurement focus is on NAICS 339113 — Surgical Appliance and Supplies Manufacturing — encompassing sterile surgical trays, advanced wound care systems, orthopedic implants, and other specialized medical devices used in combat support and garrison care. He possesses deep domain expertise in surgical instrumentation, sterilization protocols, and medical device lifecycle management, ensuring that acquisitions support mission readiness and clinical excellence across the Defense Health Agency’s global network.